New AI tool detects up to 13% more breast cancers than humans alone
A new AI tool from Kheiron Medical Technologies and Imperial College London can detect up to 13% more breast cancers than humans in breast screenings.
Mosquito modification programme aiming to eliminate malaria receives US$15m
A global programme that aims to modify mosquitoes so they are unable to transmit malaria has received a grant to fund its next phase of expansion.
£17m awarded to develop globally important vaccine hubs
Imperial researchers will lead two hubs to improve global access to life-saving vaccines.
1
Feature
Smart wearables that are pushing human performance past its limits
NMES Group’s technology gives us greater control of our muscles, with applications in fitness, therapeutics, combat training, and space.
New £28m Centre to forge the next generation of AI digital healthcare innovators
A new £28 million UKRI AI Centre for Doctoral Training at Imperial College London will train over 120 researchers to develop patient-ready technology.
1
Malaria parasite gene could be effective drug target to block transmission
A newly discovered gene in the malaria parasite could be a good target for future drugs aimed at preventing disease transmission.
Nigerian Science Prize win and presidential honour for Imperial medical engineer
An Imperial pioneer of low-cost newborn care systems in Nigeria has won the Nigeria Science prize, with congratulations from the country’s president.
5
Imperial President - College making big moves to accelerate medical innovation
Professor Hugh Brady says that Imperial is working to speed development of innovations that have potential to be as transformational as penicillin.
Fluorescence gives doctors a real-time connection with the health of the gut
Imperial and US medical technology company MediBeacon have partnered to advance a non-invasive method of assessing intestinal health.
Nanopore sequencing and DNA barcoding method gives hope of personalised medicine
With the ability to map dozens of biomarkers at once, a new method could transform testing for conditions including heart disease and cancer.
4
